Literature DB >> 21930972

Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation.

Zhenyu Yao1, Jennifer Jones, Holbrook Kohrt, Samuel Strober.   

Abstract

Our previous studies showed that treatment of mice with total body irradiation (TBI) or total lymphoid tissue irradiation markedly changes the balance of residual T cell subsets to favor CD4(+)CD44(hi) NKT cells because of the differential resistance of the latter subset to cell death. The object of the current study was to further elucidate the changed balance and mechanisms of differential radioresistance of T cell subsets after graded doses of TBI. The experimental results showed that CD4(+) T cells were markedly more resistant than CD8(+) T cells, and CD44(hi) T cells, including NKT cells and memory T cells, were markedly more resistant than CD44(lo) (naive) T cells. The memory T cells immunized to alloantigens persisted even after myeloablative (1000 cGy) TBI and were able to prevent engraftment of bone marrow transplants. Although T cell death after 1000 cGy was prevented in p53(-/-) mice, there was progressive T cell death in p53(-/-) mice at higher doses. Although p53-dependent T cell death changed the balance of subsets, p53-independent T cell death did not. In conclusion, resistance of CD44(hi) T cells to p53-dependent cell death results in the persistence of immunological memory after TBI and can explain the immune-mediated rejection of marrow transplants in sensitized recipients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930972      PMCID: PMC3186844          DOI: 10.4049/jimmunol.1101141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells.

Authors:  J M Grayson; A J Zajac; J D Altman; R Ahmed
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 2.  CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects.

Authors:  S M Kang; Q Tang; J A Bluestone
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

3.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

Authors:  P A McSweeney; D Niederwieser; J A Shizuru; B M Sandmaier; A J Molina; D G Maloney; T R Chauncey; T A Gooley; U Hegenbart; R A Nash; J Radich; J L Wagner; S Minor; F R Appelbaum; W I Bensinger; E Bryant; M E Flowers; G E Georges; F C Grumet; H P Kiem; B Torok-Storb; C Yu; K G Blume; R F Storb
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

4.  Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.

Authors:  Sema Kurtulus; Pulak Tripathi; Maria E Moreno-Fernandez; Allyson Sholl; Jonathan D Katz; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

5.  Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.

Authors:  F Lan; D Zeng; M Higuchi; P Huie; J P Higgins; S Strober
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

6.  TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

Authors:  Holbrook E Kohrt; Brit B Turnbull; Kartoosh Heydari; Judith A Shizuru; Ginna G Laport; David B Miklos; Laura J Johnston; Sally Arai; Wen-Kai Weng; Richard T Hoppe; Philip W Lavori; Karl G Blume; Robert S Negrin; Samuel Strober; Robert Lowsky
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

7.  The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning.

Authors:  R G Nador; D Hongo; J Baker; Z Yao; S Strober
Journal:  Am J Transplant       Date:  2009-12-23       Impact factor: 8.086

8.  Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

Authors:  David Valcárcel; Rodrigo Martino; Dolores Caballero; Jesus Martin; Christelle Ferra; Jose B Nieto; Antonia Sampol; M Teresa Bernal; Jose L Piñana; Lourdes Vazquez; Jose M Ribera; Joan Besalduch; Jose M Moraleda; Dolores Carrera; M Salut Brunet; Jose A Perez-Simón; Jorge Sierra
Journal:  J Clin Oncol       Date:  2007-12-17       Impact factor: 44.544

9.  Differences in Bcl-2 expression by T-cell subsets alter their balance after in vivo irradiation to favor CD4+Bcl-2hi NKT cells.

Authors:  Zhenyu Yao; Yinping Liu; Jennifer Jones; Samuel Strober
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

10.  Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.

Authors:  Asha B Pillai; Tracy I George; Suparna Dutt; Pearline Teo; Samuel Strober
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

View more
  17 in total

1.  A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells.

Authors:  Michael Förster; Rupinder K Boora; Jessica C Petrov; Nassima Fodil; Isabella Albanese; Jamie Kim; Philippe Gros; Anastasia Nijnik
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

2.  Regulators help new immigrants settle down?

Authors:  Defu Zeng
Journal:  Blood       Date:  2014-05-01       Impact factor: 22.113

Review 3.  Transplantation tolerance after allograft rejection.

Authors:  Michelle L Miller; Maria-Luisa Alegre; Anita S Chong
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

4.  Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.

Authors:  Stephan Busque; John D Scandling; Robert Lowsky; Judith Shizuru; Kent Jensen; Jeffrey Waters; Hsin-Hsu Wu; Kevin Sheehan; Asha Shori; Okmi Choi; Thomas Pham; Marcelo A Fernandez Vina; Richard Hoppe; John Tamaresis; Philip Lavori; Edgar G Engleman; Everett Meyer; Samuel Strober
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

5.  Histone deacetylation critically determines T cell subset radiosensitivity.

Authors:  Jason L Pugh; Alona S Sukhina; Thomas M Seed; Nancy R Manley; Gregory D Sempowski; Marcel R M van den Brink; Megan J Smithey; Janko Nikolich-Žugich
Journal:  J Immunol       Date:  2014-07-02       Impact factor: 5.422

Review 6.  Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.

Authors:  Samuel Strober
Journal:  Blood       Date:  2016-01-21       Impact factor: 22.113

7.  Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment.

Authors:  Antonia M S Müller; Jessica Poyser; Natascha J Küpper; Cassandra Burnett; Rose M Ko; Holbrook E K Kohrt; Mareike Florek; Pei Zhang; Robert S Negrin; Judith A Shizuru
Journal:  Blood       Date:  2014-03-03       Impact factor: 22.113

Review 8.  Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.

Authors:  Maria Esperanza Rodriguez-Ruiz; Ilio Vitale; Kevin J Harrington; Ignacio Melero; Lorenzo Galluzzi
Journal:  Nat Immunol       Date:  2019-12-23       Impact factor: 25.606

9.  T lymphocytes and normal tissue responses to radiation.

Authors:  Dörthe Schaue; William H McBride
Journal:  Front Oncol       Date:  2012-09-19       Impact factor: 6.244

Review 10.  The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.